Faeth Therapeutics grants performance options to Anand Parikh, Christopher Gerry and Josiah CraverTradingView·1 day ago, 04:23 PMFTH+1.91%
Faeth Therapeutics grants new-hire stock options for 25,500 shares at $28.19 eachPUBT·1 day ago, 03:00 PMFTH+1.91%
Market Insider: A $200M Energy Buyout and Niche Sector OverhaulsGlobal Report·Jul 22 at 04:18 AMTRSG0.00%FMTOF0.00%
Biotech Stocks At 52-Week Highs: AMWL, CUE, ICCC, SRRK, FTHrttnews·Jul 13 at 06:18 AMSRRK-3.66%CUE-2.93%
Faeth Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | FTH Stock NewsStockTitan·Jul 3 at 07:00 AMFTH+1.91%
Faeth Therapeutics CFO Brian C. Stephenson acquires USD 319,293 of common sharesPUBT·Jul 1 at 07:10 PMFTH+1.91%
Faeth Therapeutics CFO Brian C. Stephenson reports $489,159 common share purchasePUBT·Jun 26 at 06:41 PMFTH+1.91%
This Robinhood Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Fridaybenzinga_article·Jun 26 at 07:58 AMHOOD-6.57%FRST-2.23%
Faeth Therapeutics CEO Anand Kiran Parikh acquires $55,458.56 in common sharesPUBT·Jun 24 at 05:56 PMFTH+1.91%
Faeth Therapeutics CFO Brian C. Stephenson files initial beneficial ownership statementPUBT·Jun 23 at 04:22 PMFTH+1.91%
Backblaze, Infleqtion, Zeta Global And Other Big Stocks Moving Higher On Tuesdaybenzinga_article·Jun 23 at 09:06 AMEPC+3.52%BLZE-9.01%
Top Biotech Gainers: TNON Files S-1, NVCT Inks License Deal, FTH On Watch, RGNX To Resubmit BLArttnews·Jun 22 at 10:15 PMAZTR-0.55%FTH+1.91%
